BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37161372)

  • 21. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus neoadjuvant chemotherapy plus concurrent chemoradiotherapy for ascending or descending types of nasopharyngeal carcinoma: A retrospective study.
    Lin Q; Lu L; Wang X; Lin Y; Chen Y; Chen H; Chen S; Lin S; Zhang Y; Zheng P; Chen X
    Am J Otolaryngol; 2022; 43(1):103193. PubMed ID: 34509080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy.
    Hsieh HY; Huang JW; Lu CH; Lin JC; Wang L
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):99-108. PubMed ID: 29429800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of effects and postoperative clinicopathological prognosis factors of neoadjuvant chemotherapy in patients with stage Ⅰb2 and Ⅱa2 squamous cell carcinoma of the cervix].
    An JS; Zhao YX; Song Y; Li N; Huang MN; Li XG; Li B; Zhang R; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Oct; 54(10):673-679. PubMed ID: 31648443
    [No Abstract]   [Full Text] [Related]  

  • 24. Neoadjuvant Chemotherapy Followed by Radical Surgery versus Radiotherapy (with or without Chemotherapy) in Patients with Stage IB2, IIA, or IIB Cervical Cancer: A Systematic Review and Meta-Analysis.
    Ye Q; Yang Y; Tang X; Li J; Li X; Zhang Y
    Dis Markers; 2020; 2020():7415056. PubMed ID: 32802215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
    Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of safety and efficacy of laparoscopic versus abdominal radical hysterectomy in the treatment of patients with stage I a2-II b cervical cancer].
    Yang L; Yang P; Li D; Cai J; Shen Y; Dong W; Zhang Y; Xiong Z; Chen H; Min J; Wang H; Wang Y; Liang W; Wang Z
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):915-22. PubMed ID: 26887875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matched-case comparison of neoadjuvant chemotherapy in patients with FIGO stage IB1-IIB cervical cancer to establish selection criteria.
    Hu T; Li S; Chen Y; Shen J; Li X; Huang K; Yang R; Wu L; Chen Z; Jia Y; Wang S; Cheng X; Han X; Lin Z; Xing H; Qu P; Cai H; Song X; Tian X; Xu H; Xu J; Zhang Q; Xi L; Deng D; Wang H; Wang S; Lv W; Wang C; Xie X; Ma D
    Eur J Cancer; 2012 Oct; 48(15):2353-60. PubMed ID: 22503395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant Chemotherapy Followed by Radical Surgery versus Concurrent Chemo-Radiotherapy in the Treatment of Locally Advanced Cervical Cancer: A Multicenter Retrospective Analysis.
    Sala P; Bogliolo S; Barra F; Fazio A; Maramai M; Cassani C; Gardella B; Babilonti L; Giannelli F; Mammoliti S; Spinillo A; Ferrero S; Valenzano Menada M; Costantini S; Bruzzi P; Marchiolè P
    J Invest Surg; 2022 Feb; 35(2):308-314. PubMed ID: 33289585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term oncological outcomes and recurrence patterns in early-stage cervical cancer treated with minimally invasive versus abdominal radical hysterectomy: The Norwegian Radium Hospital experience.
    Sert BM; Kristensen GB; Kleppe A; Dørum A
    Gynecol Oncol; 2021 Aug; 162(2):284-291. PubMed ID: 34083029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrospective comparison of laparoscopic versus open radical hysterectomy after neoadjuvant chemotherapy for locally advanced cervical cancer.
    Cai J; Yang L; Dong W; Wang H; Xiong Z; Wang Z
    Int J Gynaecol Obstet; 2016 Jan; 132(1):29-33. PubMed ID: 26434669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term survival following neoadjuvant chemotherapy and concomitant radiochemotherapy in locally advanced cervical cancer: results of the Oncology Institute "Prof. Dr. Ion Chiricuta" experience.
    Marita A; Ordeanu C; Rancea A; Nicolae T; Nagy VM
    J Med Life; 2018; 11(1):42-50. PubMed ID: 29696064
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical outcome of FIGO 2018 stage IB3/IIA2 cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery due to lack of radiotherapy equipment: A retrospective comparison with concurrent chemoradiotherapy.
    Zeng J; Sun P; Ping Q; Jiang S; Hu Y
    PLoS One; 2022; 17(3):e0266001. PubMed ID: 35324998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimally invasive surgery and abdominal radical hysterectomy in patients with early-stage cervical cancer: A meta-analysis.
    Yu Y; Deng T; Gu S
    Int J Gynaecol Obstet; 2022 May; 157(2):255-264. PubMed ID: 34165795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer.
    Meyer LA; Cronin AM; Sun CC; Bixel K; Bookman MA; Cristea MC; Griggs JJ; Levenback CF; Burger RA; Mantia-Smaldone G; Matulonis UA; Niland JC; O'Malley DM; Wright AA
    J Clin Oncol; 2016 Nov; 34(32):3854-3863. PubMed ID: 27601552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
    Kokka F; Bryant A; Brockbank E; Powell M; Oram D
    Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Neoadjuvant Chemotherapy Plus Radical Surgery as Front Line Treatment Strategy in Patients Affected by FIGO Stage III Cervical Cancer.
    Di Donato V; Schiavi MC; Ruscito I; Visentin VS; Palaia I; Marchetti C; Fischetti M; Monti M; Muzii L; Benedetti Panici P
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):841-849. PubMed ID: 27678502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pattern of failures and clinical outcome of patients with locally advanced cervical cancer treated with a tailored integrated therapeutic approach.
    Gadducci A; Fabrini MG; Perrone F; Manfredi B; Fanucchi A; Laliscia C; Barsotti C; Scotti V; Genazzani AR; Greco C
    Anticancer Res; 2010 Sep; 30(9):3731-5. PubMed ID: 20944162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Survival Outcomes after Laparoscopic Radical Hysterectomy versus Abdominal Radical Hysterectomy in Patients with Cervical Cancer.
    Hwang JH; Kim BW
    J Minim Invasive Gynecol; 2021 May; 28(5):971-981.e3. PubMed ID: 33321255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of treatment modality on overall survival in women with advanced endometrial cancer: A National Cancer Database analysis.
    Chambers LM; Jia X; Rose PG; AlHilli M
    Gynecol Oncol; 2021 Feb; 160(2):405-412. PubMed ID: 33221023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.